paroxetine has been researched along with mocetinostat in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chung, YC; Jin, BK; Kim, SR | 1 |
Amagase, K; Gyenge, M; Kojo, A; Nukui, K; Takeuchi, K; Tanaka, A | 1 |
Bouckaert, J; Krawczyk, L; Lemri Ouadriri, S; Prévost, M; Roos, G; Semwal, S; Soubhye, J; Van Antwerpen, P | 1 |
3 other study(ies) available for paroxetine and mocetinostat
Article | Year |
---|---|
Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antidepressive Agents, Second-Generation; Blotting, Western; Brain; Dopamine; Enzyme Activation; Immunohistochemistry; Inflammation; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Motor Activity; NADPH Oxidases; Neurons; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease, Secondary; Paroxetine; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Tumor Necrosis Factor-alpha | 2010 |
Aggravation by paroxetine, a selective serotonin reuptake inhibitor, of antral lesions generated by nonsteroidal anti-inflammatory drugs in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antidepressive Agents, Tricyclic; Antioxidants; Diclofenac; Dinoprostone; Gastric Mucosa; Indomethacin; Male; Paroxetine; Peroxidase; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stomach Ulcer; Sulfhydryl Compounds; Superoxide Dismutase | 2011 |
Native glycosylation and binding of the antidepressant paroxetine in a low-resolution crystal structure of human myeloperoxidase.
Topics: Antidepressive Agents; Glycosylation; Humans; Paroxetine; Peroxidase; Polysaccharides | 2022 |